Indeed, earlier studies have shown that CCR2-KO mice exhibit a marked reduction in immune cell infiltration, fibrosis severity, and tissue damage in this model, suggesting that targeting CCR2+ monocyte-macrophage infiltration could be a potential therapeutic strategy for UPEC-orchitis (1, 13). The gene discussed is CCR2; the disease is orchitis.